Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2023 08:30 ET | Source: NurExone Biologic Inc

NurExone Granted U.S. Patent for Technology and Drug Composition of Exo-PTEN, Designed for Treating Acute Spinal Cord Injuries

TORONTO and TEL AVIV, Israel, May 16, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (the "Company" or "NurExone") (TSXV: NRX) (FSE: J90) (NRX.V), a biopharmaceutical company developing...
February 13, 2023 08:35 ET | Source: NurExone Biologic Inc

NurExone Biologic Inc. Emerges as a Promising Investment Opportunity in Biotechnology

TORONTO and TEL AVIV, Israel, Feb. 13, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V), a Toronto-listed biopharmaceutical company, is developing ExoPTEN, a...
January 13, 2023 15:00 ET | Source: Nurexone Biologic Inc

United States Patent Office Allows Patent to Exosome Biomedical Company Nurexone

HAIFA, Israel and CALGARY, Alberta, Jan. 13, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (NRX:CVE) (J90:FRA) (the “Company” or “NurExone”), a biopharmaceutical company developing...